Adial Pharmaceuticals, Inc.
ADIL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001513525
In the last 90 days, Adial Pharmaceuticals, Inc. insiders filed 2 open-market purchases and 0 sales; 17 institutions reported holding it in 13F filings for Q2 2026, worth $334.6K in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Adial Pharmaceuticals, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 23 | 21 | −2 |
| Shares | 2.51M | 2.34M | −168.4K (−6.7%) |
| Value | $876.9K | $488.2K | −$388.7K (−44.3%) |
New holders (2)
Institutions that held Adial Pharmaceuticals, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Creative Planning | 10,000 | $2.08K | 0.00% |
| Royal Bank of Canada | 964 | $0 | 0.00% |
Sold out (4)
Institutions that held Adial Pharmaceuticals, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Brown Advisory Inc | 26,040 | $9.11K |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Management | 25,000 | $8.75K |
| UBS Group AG | 10,630 | $3.72K |
| Simplex Trading, LLC | 2,748 | $0 |